首页> 外文期刊>International Current Pharmaceutical Journal >Pharmacoepidemiology of ascites and associated complications in hospitalized patients: descriptive observational study
【24h】

Pharmacoepidemiology of ascites and associated complications in hospitalized patients: descriptive observational study

机译:住院患者腹水的药物流行病学及相关并发症:描述性观察研究

获取原文
           

摘要

Ascites is the pathological accumulation of free fluid in peritoneal cavity.?The aim of the present study was to observe the prevalence, clinical management and the assessment of complications associated with ascites in hospitalized patients.?A Descriptive Observational Study was conducted at two tertiary care hospitals of Lahore. The data was collected on a data collection form containing questions regarding basic patient information, presenting symptoms, clinical management and associated complications. Verbal informed consent was taken and confidentiality was maintained. Pilot study was performed prior to performance of a full-scale research project. The results are expressed in the form of frequency and percentages. A total of fifty (50) ascitic patients were evaluated during two months. It was slightly more common in females (58%) as compared to males (42%). Common causes of Ascites were Liver Cirrhosis (80%), Chronic Renal Failure (10%), Peritoneal Malignancy and Peritoneal Tuberculosis (4%) each and Cardiac Failure (2%). The mainstay for the first line treatment in patients with cirrhosis includes education regarding dietary sodium restriction and oral diuretics. The major complications associated with Ascites were Protein malnutrition (87%), Mental Confusion (73%), Hepatorenal Syndrome (21%) and Spontaneous Bacterial Perotinitis (8%). In most patients ascites was being managed successfully by limiting the salt intake and provision of a diuretic regimen. As, ascites is a starting point for more serious complications; so, its early diagnosis should be ensured. Social media and NGOs should play their role in creating the awareness regarding this deadly disease.DOI:?http://dx.doi.org/10.3329/icpj.v4i2.21482 International Current Pharmaceutical Journal, January 2015, 4(2): 343-346
机译:腹水是腹腔内游离液体的病理性积累。本研究的目的是观察住院患者腹水的患病率,临床管理和并发症的评估。在两个三级医疗机构进行了描述性观察性研究。拉合尔的医院。数据收集在数据收集表上,其中包含有关患者基本信息,症状,临床管理和相关并发症的问题。采取口头知情同意并保持机密性。在进行全面研究项目之前先进行了先导研究。结果以频率和百分比的形式表示。在两个月内评估了总共五十(50)名腹水患者。女性(58%)比男性(42%)更常见。腹水的常见原因是肝硬化(80%),慢性肾功能衰竭(10%),腹膜恶性肿瘤和腹膜结核(4%)和心脏衰竭(2%)。肝硬化患者一线治疗的主要内容包括饮食限制钠盐和口服利尿剂方面的知识。与腹水有关的主要并发症是蛋白质营养不良(87%),精神错乱(73%),肝肾综合征(21%)和自发性细菌性骨膜炎(8%)。在大多数患者中,通过限制食盐摄入量和提供利尿剂可以成功控制腹水。腹水是更严重并发症的起点。因此,应确保其早期诊断。社交媒体和非政府组织应在提高人们对这种致命疾病的认识方面发挥作用.DOI:?http://dx.doi.org/10.3329/icpj.v4i2.21482 International Current Pharmaceutical Journal,2015年1月,4(2): 343-346

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号